Completed PHASE2 INTERVENTIONAL 2-arm NCT00825838

Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase

A Randomized Double-Blind Placebo-Controlled Clinical Trial of a Purified Chili Pepper Extract (CH-19 Sweet Extract) to Evaluate Its Safety and Efficacy for Weight and Fat Loss and Metabolism Change in Overweight or Obese Healthy Male and Female Adults

Sponsor: Ajinomoto USA, INC.

Conditions Obesity Overweight

Interventions Chronic consumption of chili pepper extract Chronic consumption of matching placebo

Updated 5 times since 2017 Last updated: Jan 20, 2009 Started: Apr 30, 2006 Primary completion: Oct 31, 2006 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Obesity and Overweight, this trial is completed. The trial is conducted by Ajinomoto USA, INC. and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ajinomoto USA, INC.

Data source: Ajinomoto USA, INC.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.